Comparison of the Effectiveness of Ultrasound and Transfer Energy Capacitive and Resistive (TECAR) Therapy in Patients With Carpal Tunnel Syndrome
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 42
- 试验地点
- 2
- 主要终点
- Visual Analog Scale (VAS)
研究概览
简要总结
Objective: The aim of this study was to evaluate the effect of Transfer Energy Capacitive and Resistive (TECAR) therapy on pain, symptom severity and function in patients diagnosed with carpal tunnel syndrome (CTS) based on clinical and electromyography (EMG) findings and to compare it with ultrasound therapy (US).
Methods: A total of 42 patients aged between 18 and 65 years, were randomly divided into two groups; group 1, US therapy 5 minutes intermittently for 2 weeks, 5 times a week, for a total of 10 sessions, group 2 TECAR therapy 5 min capacitive (CAP) and 10 min resistive (RES), 3 days a week for 2 weeks, for a total of 6 sessions. Both groups received paraffin therapy and wrist orthosis. All Patients were evaluated using the Visual Analog Scale (VAS) for pain and paresthesia levels, the Boston Carpal Tunnel Questionnaire (BCTQ) for symptom severity and functional levels. Additionally, median nerve CSA was measured by ultrasound, at the baseline, post-treatment, first and third months.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •18 years of age and over
- •had pain and numbness in their hands for more than 3 months were evaluated
- •Patients diagnosed with mild and moderate CTS by EMG
排除标准
- •metabolic, rheumatic, or neurological diseases that could affect the median nerve cross-sectional area (CSA)
- •patients who had previously undergone surgery on the wrist,
- •oncology patients,
- •pregnancy,
- •pacemakers.
结局指标
主要结局
Visual Analog Scale (VAS)
时间窗: baseline (0 th day), after-treatment (15 th day), 1th month, 3rd month
0 min , 10 is maximum pain score
Boston Carpal Tunnel Questionnaire (BCTQ)
时间窗: baseline (0 th day), after-treatment (15 th day), 1th month, 3rd month
symptom severity on functional tasks (Symptom Severity Scale), involving 11 items, and the other one on function status properly (Functional Status Scale), involving 8 items. Both subscales of BCTQ are scored between 1 and 5, and higher scores illustrate a greater degree of disability.
次要结局
- Median nerve cross-sectional area (CSA) measurement(baseline (0 th day), after-treatment (15 th day), 1th month, 3rd month)